[TimAlerts] tempted to buy $CRME here, down 42% for a quick scalp. this one has nice earning growth, I doubt it will remains in the low 3 for long


[TimAlerts] $CRME up 36% - Cardiome Pharma & Allergan (AGN) sign exclusive license agreement to commercialize Xydalba in France, the UK, Germany, Belgium, Nordic nations, and certain other European nations along with Canada and the middle east, additional terms undisclosed CRME 


[SuperAlerts] $CRME - I wonder if these after hours chasers realize that CRME is the company that is paying money for this agreement?

of 2